Video

Dr. Wakelee on Importance of NGS Testing in NSCLC

Heather Wakelee, MD, associate professor of medicine, Stanford University Medical Center, discusses the importance of next-generation sequencing testing in the treatment of patients with non–small cell lung cancer.

Heather Wakelee, MD, associate professor of medicine, Stanford University Medical Center, discusses the importance of next-generation sequencing (NGS) testing in the treatment of patients with non—small cell lung cancer (NSCLC).

The use of NGS testing is critical in patients with advanced-stage disease—especially in those with adenocarcinoma, Wakelee says. However, there are also patients with squamous histology, especially if they are never-smokers, who can develop driver mutations. Investigators tend to think that the classic patient with an oncogenic driver is a never-smoker who is diagnosed with adenocarcinoma, but patients with a smoking history can also have driver mutations, Wakelee stresses.

In a practice where resources are available, NGS testing should be done in every patient upfront. If resources are limited, conversations need to be had with patients. If a driver mutation is missed in a patient, then a physician is essentially missing out on giving that patient therapy that is not only well tolerated, but one that could potentially prolong their survival. It is a travesty when that happens, says Wakelee; as such, to avoid this from happening, NGS testing should be the standard.

Related Videos
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD
Jonathan Wesley Riess, MD, MS, an associate professor at the University of California (UC) Davis
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Laura A. Huppert, MD
Polly Niravath, MD
Arvind N. Dasari, MD, MS